Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome

CONTEXT: Patients with von Hippel-Lindau (VHL) syndrome have a 25–30% chance of developing pheochromocytoma. Although practice guidelines recommend biochemical and radiological screening every 1–2 years for pheochromocytoma in patients with VHL, there are limited data on the optimal age and frequenc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Endocrinol Metab
Main Authors: Aufforth, Rachel D., Ramakant, Pooja, Sadowski, Samira M., Mehta, Amit, Trebska-McGowan, Katarzyna, Nilubol, Naris, Pacak, Karel, Kebebew, Electron
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2015
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4667160/
https://ncbi.nlm.nih.gov/pubmed/26451910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-3045
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki